Personal pages menu

List of publications in international peer reviewed journals and books

 

  1. PAVELIĆ K., PAVELIĆ Z., HRŠAK I., Cytokinetic and morphological changes in lymphoid organs of mice with Ehrlich tumour. Iugoslav. Physiol. Pharmacol. Acta, 9: 407-415, 1973.
  2. PAVELIĆ Z., BORANIĆ M., PAVELIĆ K., VAŠAREVIĆ M., Pathogenesis of ascites in a murine transplantable reticulosarcoma type A. Z. Krebsforsch., 88: 91-95, 1976.
  3. PAVELIĆ Z., BORANIĆ M., BUNAREVIĆ A., PAVELIĆ K., DOMINIS M., VAŠAREVIĆ B., Studies on a tranplantable reticulosarcoma type A of the mouse. Period. biol., 79: 11-23, 1977.
  4. HRŠAK I., PAVELIĆ K., Effects of immunosupression or immunostimulation on the growth rate of a lymphoid and of a myeloid leukemia in mice. Cancer Immunol. Immunother., 3: 43-48, 1977.
  5. PAVELIĆ K., SLIJEPČEVIĆ M., Growth of a thymoma in diabetic mice treated with insulin. Europ. J. Cancer, 14: 675-679, 1978.
  6. PAVELIĆ Z., BORANIĆ M., PAVELIĆ K., Morphology of lymphoreticular tissues in mice with reticulosarcoma. Exp. Path., 15: 288-295, 1978.
  7. PAVELIĆ K., HRŠAK I., Effects of immunosupression on the growth of six murine tumors. Z. Krebsforsch., 92: 147-156, 1978.
  8. PAVELIĆ K., SLIJEPČEVIĆ M., PAVELIĆ J., Recovery of immune system in diabetic mice after treatment with insulin. Horm.Metab. Res., 10: 381-386, 1978.
  9. PAVELIĆ K., Aplastic carcinoma in diabetic mice: Hyperglycemia-suppressed proliferation rate and insulin synthesis by tumor cells. J. Nat. Cancer Inst., 62: 139-141, 1979.
  10. PAVELIĆ K., SLIJEPČEVIĆ M., PAVELIĆ J., IVIĆ J., AUDY-JURKOVIĆ S., PAVELIĆ Z.P., BORANIĆ M., Growth and treatment of Erlich tumor in mice with alloxan-induced diabetes. Cancer Res., 39: 1807-1813, 1979.
  11. HRŠAK I., TOMAŠIĆ J., PAVELIĆ K., VALINGER Z., Stimulation of humoral immunity by peptidoglycan monomer from Brevibacterium divaricatum. Z. Immun. Forsch., 155: 312-318, 1979.
  12. PAVELIĆ K., PAVELIĆ Z., POLJAK-BLAŽI M., ŠVERKO V., The effect of insulin on the growth of transplanted tumors in mice. Biomedicine, 31: 125-127, 1979.
  13. HRŠAK I., TOMAŠIĆ J., PAVELIĆ K., BENKOVIĆ B., On the mechanism of immunostimulatory activity of monomeric peptidoglycans. Period. biol., 81: 155-157, 1979.
  14. PAVELIĆ K., Induction of glucagon synthesis in diabetic CBA mice bearing mammary aplastic carcinomas. J. Nat. Cancer Inst., 63: 1005-1008, 1979.
  15. PAVELIĆ K., PAVELIĆ J., BENKOVIĆ B., VUK-PAVLOVIĆ S., Correlation between hyperglycemia and reduced immune reactivity in mice. IRCS Med. Sci., 8: 24, 1980.
  16. PAVELIĆ J., PAVELIĆ K., Insulin stimulated phagocytic ability and humoral immunologic response in mice. Horm. Metab. Res., 12: 42, 1980.
  17. PAVELIĆ K., Growth of a methylcholantrene-induced fibrosarcoma in mice with diabetes mellitus. Europ. J. Cancer, 16: 279-284, 1980.
  18. PAVELIĆ K., PAVELIĆ J., Glucagon suppressed proliferation rate of mammary aplastic carcinoma in mice. Horm. Metabol. Res., 12: 243-246, 1980.
  19. PAVELIĆ J., BENKOVIĆ B., PAVELIĆ K., Growth and treatment of B-16 melanoma in hypoglycemic mice. Res. Exp. Med., 177: 71-78, 1980.
  20. PAVELIĆ K., BAŠIĆ I., PAVELIĆ J., Habituation of a mammary aplastic carcinoma on diabetic conditions. J. Cancer Res. Clin. Oncol., 97: 275-287, 1980.
  21. PAVELIĆ K., PEKIĆ B., SLIJEPČEVIĆ M., POPOVIĆ M., Insulin levels in Hodkin’s disease. Brit. J. Haematol., 46: 133-135, 1980.
  22. PAVELIĆ K., HRŠAK I., Chemotherapy and immunotherapy of diabetic and non-diabetic mice bearing fibrosarcoma. Europ. J. Cancer, 16: 1297-1301, 1980.
  23. BENKOVIĆ B., PAVELIĆ J., PAVELIĆ K., The ability of melanoma B-16 cells to form colonies in the lungs of alloxan-diabetic mice. Biomedicine, 33: 135-136, 1980.
  24. PAVELIĆ K., VUK-PAVLOVIĆ S., Retarded growth of murine tumors in vivo by insulin- and glukagon-stimulated immunity and phagocytosis. J. Nat. Cancer. Inst., 66: 889-892, 1981.
  25. PAVELIĆ K., POPOVIĆ M., Insulin and glucagon secretion by renal adenocarcinoma. Cancer (Philad.), 48: 98-100, 1981.
  26. PAVELIĆ K., GABRILOVAC J., BOŽIKOV V., PAVELIĆ J., PETEK M., BORANIĆ M., Somatostatin suppresses growth of murine myeloid leukemia. Blood, 57: 805-809, 1981.
  27. PAVELIĆ K., FERLE-VIDOVIĆ A., OSMAK M., VUK-PAVLOVIĆ S., Synthesis of immunoreactive insulin in vitro by aplastic mammary carcinoma preconditioned in diabetic mice. J. Nat. Cancer Inst., 67: 687-688, 1981.
  28. PAVELIĆ K., PEKIĆ B., GABRILOVAC J., BRATIĆ-MIKEŠ V., BORANIĆ M., Hormonal changes in patients with haematological malignancies. Biomedicine, 35: 181-184, 1981.
  29. VUK-PAVLOVIĆ S., BOŽIKOV V., PAVELIĆ K., Somatostatin-reduced proliferation of murine aplastic carcinoma conditioned to diabetes. Int. J. Cancer, 29: 683-686, 1982.
  30. BORANIĆ M., GABRILOVAC J., PAVELIĆ J., FERLE-VIDOVIĆ A., PAVELIĆ K., ŠKARIĆ Đ., ŠKARIĆ V., Tetrapeptide H-Tyr-His-Lys-Lys-OH interferes with proliferation of normal and malignant cells in vitro. Acta Pharm. Jugosl., 32: 105-.112, 1982.
  31. GABRILOVAC J., PAVELIĆ J., MARUŠIĆ S., ORŠANIĆ L., SUCHANEK E., PAVELIĆ K., Anabolic hormone levels in immunized rats. Immunology Letters, 4: 345-347, 1982.
  32. PAVELIĆ K., BOLANČA M., VEČEK N., PAVELIĆ J., MAROTTI T., VUK-PAVLOVIĆ S., Carcinomas of the cervix and corpus uteri in humans: Stage-dependent blood levels of substance(s) immunologically cross-reactive with insulin. J. Nat. Cancer Inst., 68: 891-894, 1982.
  33. PAVELIĆ K., RADIĆ S., PAVELIĆ J., Different endocrinological properties, growth rate and sensitivity to chemotherapy of aplastic mammary carcinoma in normo- and hypoglycemic phase of tumor growth. Res. Exp. Med., 181: 63-76, 1982.
  34. PAVELIĆ K., ODAVIĆ M., PEKIĆ B., HRŠAK I., VUK-PAVLOVIĆ S., Correlation of substance(s) immunologically cross-reactive with insulin, glucose and growth hormone in Hodkin lymphoma patients. Cancer Letters, 17. 81-86, 1982.
  35. VUK-PAVLOVIĆ S., PAVELIĆ K., Towards in vitro verification of a hormone mediated feed-back mechanism of tumor growth. Period. biol., 84: 336-338, 1982.
  36. PAVELIĆ K., SIROTKOVIĆ M., KOPITAR M., PAVELIĆ J., VUK-PAVLOVIĆ S., Murine myeloid leukemia: in vivo suppression by serycystatin A, a proteinase inhibitor from leukocytes. Europ. J. Cancer. Clin. Oncol., 19: 123-126,1983.
  37. PAVELIĆ K., VUK-PAVLOVIĆ S., C-peptide does not parallel increases of substances immunologically cross-reactive with insulin in non-Hodgkin lymphoma patients. Blood, 61: 925-928, 1983.
  38. PAVELIĆ K., PETRUŠIĆ LJ., OSMAK M., ČULO F., In vitro and in vivo effect of progesterone on growth of some mouse and human tumors. Res. Exp. Med., 183: 183-191, 1983.
  39. ŽUPANOVIĆ Ž., GABRILOVAC J., BRAYER D., ROČIĆ B., PAVELIĆ K., Insulin receptors on cells of mouse myeloid leukemia. Period. Biol., 85: 97-98, 1983.
  40. PAVELIĆ LJ., PAVELIĆ K., VUK-PAVLOVIĆ S., Human mammary and bronchial carcinomas. In vivo and in vitro secretion of substances immunologically cross-reactive with insulin. Cancer, 53: 2467-2471, 1984.
  41. BAJZER Ž., PAVELIĆ K., VUK-PAVLOVIĆ S., Growth self-incitement in murine melanoma B-16, a phenomenological model. Science, 225: 930-932, 1984.
  42. MAROTTI T., SIROTKOVIĆ M., PAVELIĆ J., GABRILOVAC J., PAVELIĆ K., In vivo effect of progesteron and estrogen on tymus mass and T-cell functions in female mice. Horm. Metab. Res., 16: 201-203, 1984.
  43. PAVELIĆ K., ZGRADIĆ I., OSMAK M., POPOVIĆ M., Estramustine phosphate-reduced proliferation of murine and human cell lines and murine transplantable tumors. Res. Exp. Med., 185: 233-243, 1985.
  44. BALTIĆ V., LEVANAT S., PETEK M., BRATIĆ-MIKEŠ V., PAVELIĆ K., VUK-PAVLOVIĆ S., Elevated levels of substances immunologically cross-reactive with insulin in blood of patients with malignant pulmonary tissue proliferation. Oncology, 42: 174-178, 1985.
  45. PAVELIĆ K., L-ascorbic acid-induced DNA strand breaks and cross links in human neuroblastoma cells. Brain Res., 342: 369-373, 1985.
  46. PAVELIĆ K., BEERMAN T.A., BERNACKI R.J., An evaluation of the effects of combination chemotherapy in vitro using DNA-reactive agents. Cancer Drug Deliver., 2: 255-270, 1985.
  47. PAVELIĆ K., PEKIĆ B., Elecrophoretic distribution and dissociation into subunits of lactate dehydrogenase derived from human myeloid leukemia cells before and after induction of differentiation. J. Cell Physiol., 126: 307-311, 1986.
  48. PAVELIĆ K., VRBANEC D., MARUŠIĆ S., LEVANAT S., ČABRIJAN T., Autocrine tumor growth regulation by somatomedin C: an in vitro model. J. Endocrinol., 109: 233-238, 1986.
  49. VUK-PAVLOVIĆ Z., PAVELIĆ K., VUK-PAVLOVIĆ S., Modulation of in vitro growth of murine myeloid leukemia by an autologous substance immunochemically cross-reactive with insulin and antiinsulin serum. Blood., 67: 1031-1035, 1986.
  50. VUK-PAVLOVIĆ S., OPARA E.C., LEVANAT S., VRBANEC D., PAVELIĆ K., Autocrine tumor growth regulation and tumor-associated hypoglycemia in murine melanoma B16 in vivo. Cancer Res., 46: 2208-2212, 1986.
  51. PAVELIĆ K., BULBUL M.A., SLOCUM H.K., PAVELIĆ Z.P., RUSTUM Y.M., NIEDBALA M.J., BERNACKI R.J., Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants. Cancer Res., 46: 3653-3662, 1986.
  52. BULBUL M.A., PAVELIĆ K., SLOCUM H.K., FRANKFURT O.S., RUSTUM Y.M., HUBEN R.P., BERNACKI R.J., Growth of human urologic tumors on extracellular matrix. J. Urology, 136: 512-516, 1986.
  53. PAVELIĆ K., Calmodulin antagonist W13 prevents DNA repair after bleomycin treatment of human urological tumor cells growing on extracellular matrix. Int. J. Biochemistry, 19: 1091-1095, 1987.
  54. PAVELIĆ K., BERNACKI R.J., VUK-PAVLOVIĆ S., Insulin-modulated interleukin-2 production by murine splenocytes and T-cell hybridoma. J. Endocrinology, 114: 89-94, 1987.
  55. KOS Z., PAVELIĆ LJ., PEKIĆ B., PAVELIĆ K., Reversal of human myeloid leukemia cells into normal granulocytes and macrophages: activity and intracellular distribution of catalase. Oncology, 44: 245-247, 1987.
  56. PAVELIĆ K., SPAVENTI Š., Nerve growth factor (NGF) induced differentiation of human neuroblastoma cells. Int. J. Biochemistry, 19: 1237-1240, 1987.
  57. ČABRIJAN T., PAČARIZI H., LEVANAT S., VRBANEC D., PAVELIĆ J., MILKOVIĆ D., SPAVENTI R., KONČAR M., BALTIĆ V., SPAVENTI Š., PAVELIĆ K., Autocrine tumor growth regulation by the insulin growth factor I (IGF I) and the epidermal growth factor (EGF). Progress in Cancer and Therapy, Vol. 35, Hormones and Cancer 3, edited by F. Bresciani, R.J.B. King, M.E. Lippman and J.P. Raynaud. Raven Press, Ltd. New York, 227-230, 1988.
  58. BERNACKI R.J., PAVELIĆ K., SULLIVAN C.L., LETO G., BULBUL M.A., RUSTUM Y.M., NIEDBALA M.J., CRICKARD K., Interactions of human carcinoma cells with extracellular matrix. Tumor Progression and Metastasis, edited by G.I.. Nicolson and I.J. Fidler. Alan R. Liss, Inc., New York, 251-260, 1988.
  59. ČABRIJAN T., PAČARIZI H., LEVANAT S., VRBANEC D., PAVELIĆ J., MILKOVIĆ D., SPAVENTI R., KONČAR M., BALTIĆ V., SPAVENTI Š., PAVELIĆ K., Autocrine tumor growth regulation by the insulin growth factor I (IGF I) and the epidermal growth factor (EGF). In: Progress in Cancer and Therapy, Vol. 35, Hormones and Cancer 3, (edited by Bresciani F, King RJB, Lippman ME and Raynaud JP). Raven Press, Ltd. New York, 227-230, 1988.
  60. BERNACKI RJ, PAVELIĆ K., SULLIVAN C.L., LETO G., BULBUL M.A., RUSTUM Y.M., NIEDBALA M.J., CRICKARD K., Interactions of human carcinoma cells with extracellular matrix.In: Tumor Progression and Metastasis, (edited by Nicolson GL and Fidler IJ). Alan R. Liss, Inc., New York, 251-260, 1988.
  61. OSMAK M., SIROTKOVIĆ M., LEVANAT S., KORBELIK M., PAVELIĆ K., Substance immunologically cross-reactive with insulin (SICRI) stimulates cell division. Oncology, 46: 54-57, 1989.
  62. LEVANAT S., PAVELIĆ K., Isolation and purification of a substance immunologically cross-reactive with insulin (SICRI) from human tissue. Int. J. Biochemistry 21: 509-515, 1989.
  63. KRUŠLIN B., LEVANAT S., BALTIĆ V., MILKOVIĆ D., PAVELIĆ J., SPAVENTI R., SPAVENTI Š., PAVELIĆ K., Growth factors in human tumors. Res. Exp. Med., 189: 91-99, 1989.
  64. PAVELIĆ K., KOS Z., SPAVENTI Š., Antimetabolic activity of L-ascorbic acid in human and animal tumors. Int. J. Biochemistry, 21:931-935, 1989.
  65. SPAVENTI R., ANTICA M., PAVELIĆ K., Insulin and insulin-like growth factor I (IGF I) in early mouse embryogenesis. Development, 108: 491-495, 1990.
  66. PAČARIZI H., SPAVENTI R., SPAVENTI Š., LEVANAT S., PAVELIĆ J., PAVELIĆ K., The expression of growth factors in human melanomas. Tumordiagn.Ther.11: 37-40, 1990.
  67. LEVANAT S., PAVELIĆ K., Substance immunologically cross-reactive with insulin from murine myeloid leukemia: purification and characterization. Biol. Chem. Hoppe-Seyler, 371: 249-254, 1990.
  68. PAVELIĆ K., BALTIĆ V., SPAVENTI Š., Artificial reversion of acute myeloid leukemia cells into hormonal phenotype. Int. J. Biochemistry, 22: 533-538, 1990.
  69. MARUŠIĆ-GALEŠIĆ S., PAVELIĆ K., Dynamics of positive and negative selection in the thymus: review and hypothesis. Immunology Letters, 24:149-154, 1990.
  70. PAVELIĆ K., DESPOT N., LEVANAT S., ČASL T., Protective role of transforming growth factor beta (TGF b) in tumor-induced degradation of basement membranes. Biol. Chem. Hoppe-Seyler, 371:687-692, 1990.
  71. OSMAK M., ECKERT-MAKSIĆ M., PAVELIĆ K., MAKSIĆ Z.B., SPAVENTI R, BEKETIĆ L, KOVAČEK I, ŠUŠKOVIĆ B., 6-Deoxy-6-bromo-ascorbic acid inhibits growth of mouse melanom cells. Res. Exp. Med. 190:443-449, 1990.
  72. PAVELIĆ K., PAVELIĆ Z.P., DENTON D., REISING J., KHALILY M., PREISLER H.D., Immunohistochemical detection of C-MYC oncoprotein in paraffin embedded tissues. J. Exp. Pathol. 5: 143-153, 1990.
  73. PAVELIĆ Z.P., PAVELIĆ LJ., PAVELIĆ K., PEACOCK J.S., Utility of anti-carcinoembryonic antigen monoclonal antibodies for differentiating ovarian adenocarcinomas from gastrointestinal metastasis to the ovary. Gynecologic Oncology, 40: 112-117, 1991.
  74. MARUŠIĆ-GALEŠIĆ S., PAVELIĆ K., POKRIĆ B., Cellular immune response to the antigen administered as an immune complex. Immunology, 72: 526-531, 1991.
  75. PAVELIĆ J., ZGRADIĆ I., PAVELIĆ K., Presence of estrogen receptors on target cells and antiproliferative activity of estramustine phosphate: positive correlation for human tumours in vitro. J. Cancer. Res. Clin. Oncol. 117: 244-248, 1991.
  76. ECKERT-MAKSIĆ M., KOVAČEK I., MAKSIĆ Z.B., OSMAK M., PAVELIĆ K., Effect of ascorbic acid and its derivatives on different tumors in vivo and in vitro . Molecules in Natural Science and Medicine, An Encomium for Linius Pauling, edited by Z.B. Maksić and M. Eckert-Maksić. Ellis Horwood, New York/London/Toronto/Sydney/Tokyo/Singapore, 509-524, 1991.
  77. PAVELIĆ K., PAVELIĆ Z.P., PREISLER H.D., C-MYC detection in bone marrow biopsies. Leukemia Res. 15, 1075-1078,1991.
  78. SLADE N., LEVANAT S., SPAVENTI Š., PAVELIĆ K., Collagenase derived from human fibrosarcoma is responsible for degradation of basement membranes. Int. J. Exp. Pathol. 72, 715-724,1991.
  79. ČABRIJAN T., LEVANAT S., PEKIĆ B., PAVELIĆ J., SPAVENTI R., FRAHM H., ZJAČIĆ-ROTKVIĆ V., GOLDONI V., VRBANEC D., MISJAK M., GRAZIO S., PAVELIĆ K., The role of insulin-related substance in Hodgkin’s disease. J. Cancer Res. Clin. Oncol. 117, 615-619,1991.
  80. PAVELIĆ Z.P., PAVELIĆ LJ., PAVELIĆ K., GENTA R.M., RAY M.B., DVORNIK G., ŠĆUKANEC-ŠPOLJAR M., PEACOCK J.S., Expression of carcinoembryonic antigen in ulcerative colitis, tubular adenomas and hyperplastic polyps: correlations with degree of dysplasia. Anticancer Res. 11, 1671-1676, 1991.
  81. PAVELIĆ K., PEĆINA N., SPAVENTI R., Growth factor and proto-oncogenes in early mouse embryogenesis. Int. J. Dev. Biol. 35: 209-214, 1991.
  82. BANAVALI S.D., SILVESTRI F.F., PAVELIĆ K., PAVELIĆ Z.P., SMITH P.L., PREISLER H.D., Studies of the geographic patterns of c-myc expression in bone marrow. Cell Prolif. 24: 529-542, 1991.
  83. PAVELIĆ Z.P., PAVELIĆ LJ., PAVELIĆ K., DVORNIK G., ŠĆUKANEC-ŠPOLJAR M., PEACOCK J.S., Immunohistochemical detection of carcinoembryonic antigen (CEA) with anti-CEA monoclonal antibodies in conventional tissue sections. Period. biol. 93: 479-484, 1991.
  84. ECKERT-MAKSIĆ M, KOVAČEK I, MAKSIĆ ZB, OSMAK M, PAVELIĆ K., Effect of ascorbic acid and its derivatives on different tumors in vivo  and in vitro . In: Molecules in Natural Science and Medicine, An Encomium for Linius Pauling, (edited by Maksić ZB and Eckert-Maksić M). Ellis Horwood, New York//London/Toronto/Sydney/Tokyo/Singapore 509-524, 1991.
  85. PAVELIĆ Z.P., PAVELIĆ K., CARTER C.P., PAVELIĆ LJ., Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast. J. Cancer Res. Clin. Oncol. 118: 16-22, 1992.
  86. SEVER Z., PAVELIĆ J., LEVANAT S., SPAVENTI R., SLADE N., JELIĆ I., BALTIĆ V., PAVELIĆ LJ., ČABRIJAN T., ČASL T., PAVELIĆ K., Insulin-related substances in human solid tumors. Tumordiagn. u. Ther. 13: 54-59, 1992.
  87. OSMAK M., PEĆINA N., PAVELIĆ K., Multiple fractions of gamma rays increase the expression of p62c-myc in Chinese hamster V79 cells. Period. biol. 94: 59-64, 1992.
  88. ŠTORGA D., PEĆINA-ŠLAUS N., PAVELIĆ J., PAVELIĆ Z.P., PAVELIĆ K., c-fms is present in primary tumours as well as in their metastases in bone marrow. Int J. Exp. Path. 73: 527-533, 1992.
  89. POLJAK LJ., VERSTOVŠEK S., KNEŽEVIĆ N., UŽAREVIĆ B., BATINIĆ D., PAVELIĆ K., MARUŠIĆ-GALEŠIĆ S., Cyclosporine A differently affects the function of the two Main T cell subsets. Croatian Med. J. 33: 102-106, 1992.
  90. PAVELIĆ K., ANTONIĆ M., PAVELIĆ LJ., PAVELIĆ J., PAVELIĆ Z., SPAVENTI Š., Human lung cancers growing on extracellular matrix: Expression of oncogenes and growth factors. Anticancer Res. 12: 2191-2196,1992.
  91. GRAZIO S., FRKOVIĆ-GRAZIO S., ČABRIJAN T., ZJAČIĆ-ROTKVIĆ V., GOLDONI V., PEĆINA-ŠLAUS N., KAMENJICKI E., PAVELIĆ K., Freshly frozen subsequently AMeX processed breast carcinoma tissue - a new possibility for immunohistochemical detection of c-myc oncoprotein. Period. biol. 94: 215-220, 1992.
  92. KAPITANOVIĆ S., SPAVENTI R., KUŠIĆ B., PAVELIĆ K., c-erbB-2/neu in colorectal carcinoma: A potential prognostic value? Eur. J. Cancer, 29A: 170-170, 1993.
  93. GALL-TROŠELJ K., PAVIČIĆ D., AUDY-JURKOVIĆ S., PAVELIĆ J., PAVELIĆ K., PCR amplification of DNA from stained cytological smears. J. Clin. Pathol. 46: 378-379,1993.
  94. HORVAT Š., HORVAT J., VARGA-DEFTERDAROVIĆ L., PAVELIĆ K., CHUNG N.N., SCHILLER P.W. Methionine-enkephalin related glycoconjugates. Synthesis and biological activity. Int. J. Peptide Protein Res. 41: 399-404, 1993.
  95. PUJIĆ N., HEGEDIS LJ., PAVELIC K., CASL T., MARUSIC S., SAVOVSKI K., DUJIC A., DIMITRIJEVIC B., Humoral stimulating activities in post-cyclophosphamide rat sera and their purified fractions. Cell Prolif. 26: 1-11, 1993.
  96. GALL K., PAVELIĆ J., JADRO-ŠANTEL D., POLJAK M., PAVELIĆ K. DNA amplification by polymerase chain reaction from brain tissues embedded in paraffin. Int. J. Exp. Path. 74: 333-337, 1993.
  97. POLJAK LJ., PEĆINA N., DŽUBUR A., UŽAREVIĆ B., VITALE B., PAVELIĆ K.: Modulation of p62c-myc expression in a single case of non-T acute lymphoblastic leukemia (ALL) assessed by image analyzer. Tumordiagn.u.Ther. 14:158-162,1993.
  98. PAVELIĆ K, BANJAC Ć, PAVELIĆ J, SPAVENTI Š.: Evidence for a role of EGF receptor in the progression of human lung carcinoma. Anticancer Res. 13:1133-1138, 1993.
  99. SPAVENTI R., PEČUR L., PAVELIĆ K., PAVELIĆ Z.P., SPAVENTI Š., STAMBROOK P.J.: Human Tumour Bank in Croatia: a Possible Model for a Small Bank as a Part of the Future European Tumour Bank Network. Eur.J.Cancer 30A:419-419, 1994.
  100. KAPITANOVIĆ S., SPAVENTI R., POLJAK LJ., KAPITANOVIĆ M., PAVELIĆ Z.P., GLUCKMAN J.L., SPAVENTI Š., PAVELIĆ K.: High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters. Cancer Detect. Prevent. 18: 97-101,1994.
  101. KNEŽEVIĆ V., SPAVENTI R., POLJAK LJ., SLADE N., ŠVAJGER A., PAVELIĆ K.: p185neu is expressed in yolk sac during rat postimplantation development. J. Anat. 185: 181-187, 1994.
  102. SPAVENTI R., PAVELIĆ K., PAVELIĆ Z.P., GLUCKMAN J.L.: The concomitant expression of oncogenes ans growth factors in human breast cancer. Eur.J.Cancer 30A:723-724, 1994.
  103. SPAVENTI R., KAMENJICKI E., PECINA N., GRAZIO S., GRAZIO S., PAVELIC J., KUSIC B., CVRTILA D., DANILOVIC Z, SPAVENTI S., PAVELIC K., GLUCKMAN J., PAVELIC Z.P.: Immunohistochemical detection of TGF-a, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: A concomitant expression? In vivo 8:183-190, 1994.
  104. PAVELIĆ J., GALL-TROŠELJ K., HLAVKA V., PAVELIĆ Z.P., GLUCKMAN J.L., STAMBROOK P.J., PAVELIĆ K.: nm23-H1 protein in oligodendrogliomas. Int. J. Oncol. 4:1399-1403, 1994.
  105. PEĆINA-ŠLAUS N., PAVELIĆ J., PAVELIĆ K.: Comparison of reverse-phase HPLC and gel electrophoretic purification of synthetic oligonucleotides. Period. biol. 96:161-164, 1994.
  106. ILIJAS M., PAVELIC K., SARCEVIC B., KAPITANOVIC S., KURJAK A., STAMBROOK P.J., GLUCKMAN J.L., PAVELIC Z.P.: Expression of nm23-H1 gene in squamous cell carcinoma of the cervix correlates with 5-year survival. Int. J. Oncol.5: 1455-1457, 1994.
  107. SARIC T., SEITZ H.J., PAVELIC K.: Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme. Mol. Cell. Endocr., 106:23-29, 1994.
  108. PAVELIĆ J., HLAVKA V., POLJAK M., GALE N., PAVELIĆ K.: p53 immunoreactivity in oligodendrogliomas. J. Neuro-Oncol. 22:1-6, 1994.
  109. PAVELIC Z.P., LI Y-Q., STAMBROOK P.J., McDONALD J.S., MUNCK-WIKLAND E., PAVELIC K., DACIC S., DANILOVIC Z., PAVELIC, LJ., MUGGE R.E., WILSON K., NGUYEN C., GLUCKMAN J.L.: Overexpression of p53 protein is common in premalignant head and neck lesions. Anticancer Res. 14: 2259-2266, 1994.
  110. PECUR L., KAPITANOVIĆ S., SONICKI Z, PAVIČIĆ F., SPAVENTI Š., SPAVENTI R., GLUCKMAN J.L., STAMBROOK P.J., PAVELIC Z.P., SPAVENTI R., PAVELIC K.P.: Prognostic significance of transforming growth factor alpha (TGF-a) in human lung carcinoma: An immunohistochemical study. Anticancer Res. 14:2839-2844, 1994.
  111. PAVELIC Z.P., LI Y-Q., STAMBROOK P.J., MUNCK-WIKLAND E., PAVELIC K., McDONALD J.S., DACIC S., DANILOVIC Z., PAVELIC, LJ., MUGGE R.E., WILSON K., NGUYEN C., KLUSMAN P., GLUCKMAN J.L.: p53 mutation and expression during multistage human head and neck carcinogenesis. Proceedings of the XVI International Cancer Congress, New Delhi, India, 30.10.-5.5.1994. edited by R.S. Rao, M.G. Deo and L.D. Sanghvi. Monduzzi Editore S.p.A. Bologna, 923-927, 1994.
  112. SLADE N., PAVELIĆ J., KRUŠLIN B., PAVELIĆ K.: Type IV collagenase in squamous cell and basal cell skin carcinomas. Arch. Dermat. Res. 287:512-514, 1995.
  113. GRDIŠA M., KRALJ M., ECKERT-MAKSIĆ M., MAKSIĆ Z.B. 6-amino-6-deoxyascorbic acid induces apoptosis in human tumor cells. J. Cancer Res. Clin. Oncol., 121:98-102, 1995.
  114. KAPITANOVIĆ S., SPAVENTI R., VUJISIĆ S., PETROVIĆ Z., KURJAK A., PAVELIĆ Z.P., GLUCKMAN J.L., STAMBROOK P.J., PAVELIC K. nm23-H1 gene expression in ovarian tumors - a potential tumor marker. Anticancer Res., 15:587-590, 1995.
  115. GALL-TROŠELJ K., KUŠIĆ B., PEĆINA-ŠLAUS, N., PAVELIĆ K., PAVELIĆ J. Nested polymerase chain reaction for detection of hepatitis C virus RNA in blood derivatives. Eur J Clin Chem Clin Biochem, 33:733-736, 1995.
  116. SLADE N., KUZMIĆ I., POLJAK LJ., KRUŠLIN B., PAVELIĆ K., PAVELIĆ J. Inverse relation between type IV collagenase and TGF-b1 in human endometrial carcinoma. Tumordiagn. u. Ther. 16:230-231, 1995.
  117. PAVELIĆ K., HRAŠČAN R., KAPITANOVIĆ S., KARAPANDŽA N., VRANEŠ Z., BELICZA M., KRUŠLIN B., ČABRIJAN T. Multiple genetic alterations in malignant matastatic insulinomas. J. Pathol, 178:395-400, 1995.
  118. PAVELIĆ K. Human tumor bank: Editorial. Period. biol. 97: 11-12, 1995.
  119. KRALJ M., KOJIĆ-PRODIĆ B., BANIĆ Z., GRDIŠA M., VELA V., ŠUŠKOVIĆ B., PAVELIĆ K. Synthesis, structural characterization and cytotoxic effect of 6-amino-6-deoxy-L-ascorbic acid derivatives. Eur. J. Med. Chem. 31:23-35, 1996.
  120. PAVELIĆ K. Is tumour suppressor gene p53 involved in neuroendocrine tumour carcinogenesis. J. Pathol, 178:359-360, 1996.
  121. PAVELIĆ J., GALL-TROŠELJ K., HERAK BOSNAR M., KARDUM M.M., PAVELIĆ K.: PCR amplification of DNA from archival specimens. A methodological approach. Neoplasma, 43:75-81, 1996.
  122. GRCE M., MAGDIĆ L., KOCIJAN I., PAVELIĆ K.: Increase of genital human papillomavirus infection among men and women in Croatia. Anticancer Res., 16:1039-1042, 1996.
  123. PAVELIC K., HRASCAN R., KAPITANOVIC S., VRANES, Z., CABRIJAN T., SPAVENTI S., KORSIC M., KRIZANAC S., LI Y.-Q., STAMBROOK P., GLUCKMAN J.L., PAVELIC Z.P.: Molecular genetics of malignant insulinoma. Anticancer Res., 16:1707-1718, 1996.
  124. HRAŠĆAN., R., PAVELIĆ, K., PAVIČIĆ, D., KRIŽANAC, Š., ŠTAJCER-ŠTITIĆ, V., PEČUR, L., SPAVENTI, Š., KLIMPFINGER, M., PAVELIĆ, J.. Concomitant point mutation of tumor suppressor gene p53 and oncogenbe c.N.ras in malignant neuroendocrine pancreatic tumor. Anticancer Res., 16:3761-3766, 1996.
  125. STEINER-BIOCIC, I., GLAVAS-OBROVAC, L. KARNER, I., PIANTANIDA, I., ZINIC, M., PAVELIC, K., PAVELIC, J:.4,9-Diazapyrenium dications induce apoptosis in human tumor cells. Anticancer Res., 16:3705-3708, 1996.
  126. KRUŠLIN, B., HRAŠĆAN, R., MANOJLOVIĆ, S., PAVELIĆ, K.: Oncoproteins and tumor suppressor proteins in congenital sacrococcygeal teratomas. Pediatr. Pathol. Lab. Med., 17:43-52, 1977.
  127. POPOVIĆ-HADŽIJA, M., POLJAK-BLAŽI, M., PAVELIĆ, K.: Presence of c-MYC protein in murine myeloid leukaemia cells during growth and after irradiation. Anticancer Res., 17:1089-1092, 1997.
  128. GRCE,M., FURČIĆ I., HRAŠČAN, R., HUSNJAK, K., KRHEN, I., MAREKOVIĆ, Z., ZELJKO Ž., PAVELIĆ, K.: Human Papillons viruses are not associated with renal carcinoma. Anticancer Res., 17:2193-2196, 1997.
  129. KAPITANOVIĆ S., RADOŠEVIĆ, S., KAPITANOVIĆ, M., ANĐELINOVIĆ, Š., FERENČIĆ, Ž., TAVASSOLI, M., PRIMORAC, D., SONICKI Z., SPAVENTI Š., PAVELIĆ, K., SPAVENTI, R.: The expression of p185 HER-2/neu correlates with the stage of disease and survival in colorectal cancer. Gastroenterology, 112:1103-1113, 1997.
  130. GRCE, M., HUSNJAK, K., MAGDIĆ, L., ILIJAŠ, M., ZLAČKI, M., LEPUŠIĆ, D., LUKAČ, J., HODEK, B., GRIZELJ, V., KURJAK, A., KUSIĆ., Z., PAVELIĆ, K.: Detection and typing of human papillomaviruses by polymerase chain reaction in cervical scrapes of Croatian women with abnormal cytology. Europ. J. Epidem., 13:645-651, 1997.
  131. HERAK-BOSNAR M., PAVELIĆ, K., HRAŠČAN, R., ZELJKO Ž., KRHEN I., MAREKOVIĆ, Z., KRIŽANAC, Š., PAVELIĆ, J.: Loss of heterozygosity of the nm23-H1 gene in human renal cell cacinomas. J. Cancer Res. Clin Oncol., 123:485-488, 1997.
  132. HERAK BOSNAR, M., PAVELIĆ, K., KRIŽANAC, Š., SLOBODNJAK, Z., PAVELIĆ, J.: Squamous cell lung carcinomas: the role of nm23-H1 gene. J.Mol. Med., 75:609-613, 1997.
  133. HEĆIMOVIĆ, S., BARIŠIĆ, I., MULLER, A., PETKOVIĆ, I., BARIĆ, I., LIGUTIĆ, I., PAVELIĆ, K.: Expand long PCR for fragile X mutation detection. Clin. Genet., 52:147-154, 1997.
  134. PAVELIĆ, K., HRAŠĆAN, R., ČABRIJAN, T., KRIŽANAC, D., ELJUGA, D., PAVELIĆ, K., KARAPANDŽA, N., KUSIĆ, Z., SPAVENTI, Š., PAVELIĆ, J.: Point mutation of tumor suppressor gene p53 in two highly malignant metastatic insulinomas. Tumordiagn.u.Ther. 18:102-106, 1997.
  135. MRAVAK-STIPETIĆ, M., GALL-TROŠELJ, K., LUKAČ, J., KUSIĆ,Z., PAVELIĆ, K., PAVELIĆ, J.: Detection of Helicobacter pylori in various oral lesions by nested polymerase chain reaction (PCR). J. Oral. Pathol. Med., 27:1-3, 1998.
  136. PAVELIĆ, K., ČABRIJAN, T.,HRAČŠAN, R., VRKLJAN, M., LIPOVAC., M., KAPITANOVIĆ, S., GALL-TROŠELJ, K., HERAK BOSNAR, M., TOMAC, A., GRŠKOVIĆ, B., KARAPANDŽA, N., PAVELIĆ, LJ., KRUŠLIN, B., SPAVENTI, Š., PAVELIĆ, J.: Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: oncogenes, tumor-suppressor genes and the insulin-like growth factor family. J. Cancer Res. Clin. Oncol., 124:307-314, 1998.
  137. GRDIŠA, M., LOPOTAR, N., PAVELIĆ, K.: Effect of a 17-member azalide on tumor cell growth. Chemotherapy 44:331-336, 1998.
  138. HEĆIMOVIĆ, S., BARIŠIĆ, I., PAVELIĆ, K.: DNA alalysis of the fragile X syndrome in an at risk pediatric population in Croatia: simple clinical preselection criteria can considerably improve the cost-effectiveness of fragile X screening studies. Human Hered., 48:256-265, 1988.
  139. ILIJAŠ, M., KAPITANOVIĆ, S., ŠARČEVIĆ, B., PAVELIĆ, K., PAVELIĆ, Z.P., KURJAK, A., PAVELIĆ J.: Gene nm23-H1 - possible prognostic factor for invasive squamous cell carcinoma of cervix uteri. J. Tumour Marker Oncol., 13:61-67, 1998.
  140. PAVELIĆ, J., GALL-TROŠELJ, K., MRAVAK-STIPETIĆ, M., PAVELIĆ, K.: The p53 and nm23-H1 Genes are not Deleted in Oral Benign Epithelial Lesions. Anticancer Res., 18:3527-3532, 1998.
  141. HEČIMOVIĆ, S., BARIŠIĆ, I., MARKOVIĆ, D., ŠKARPA, I., RELJA, M., PAVELIĆ, K.: Trinucleotide repeat diseases - DNA molecular analysis using a simple expand long PCR assay. Period. biol., 100: 353-360, 1998.
  142. ŠTURLAN, S., KAPITANOVIĆ, S., KOVAČEVIĆ, D., LUKAČ, J., SPAVENTI, Š., SPAVENTI, R., PAVELIĆ, K.: Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer. J. Mol. Med., 77: 316-321, 1999.
  143. PAVELIĆ, K., PAVELIĆ, Z.P., ČABRIJAN, T., KARNER, I., SAMARŽIJA, M., STAMBROOK, P.J.: Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor. J. Pathol., 188: 69-75, 1999.
  144. KATIĆ, M., HADŽIJA, M., WRISCHER, M., PAVELIĆ, K.; An in vitro model of the early genetic events in multistage carcinogenesis of malignant insulinoma. Carcinogenesis, 20: 1521-1527, 1999.
  145. RAIĆ-MALIĆ, S., HERGOLD-BRUNDIĆ, A., NAGL, A., GRDIŠA, M., PAVELIĆ, K., DE CLARCG, E., MINTAS, M.: Novel pyrimidine and purine derivatives of L-ascorbic Acid: synthesis and biological evaluation. J. Med. Chem., 42: 2673-2678, 1999.
  146. PEĆINA-ŠLAUS, N., PAVELIĆ, K., PAVELIĆ, J.: Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas. J. Mol. Med., 77: 446-453, 1999.
  147. PAVELIĆ K., SPAVENTI Š., GLUNČIĆ V., MATEJČIĆ A., PAVIČIĆ D., KARAPANDŽA N., KUSIĆ Z., LUKAĆ J., ČABRIJAN T., PAVELIĆ J.: The expression and role of insulin-like growth factor II in malignant hemangiopericytomas. J. Mol. Med.., 77:865-869,1999.
  148. SLADE N., ŠTORGA-TOMIĆ D., BIRKMAYER GD., PAVELIĆ K., PAVELIĆ J: Effect of extracellular NADH on human tumor cell proliferation. Anticancer Res., 19:5355-5360,1999.
  149. RAIĆ-MALIĆ S., GRDIŠA M., PAVELIĆ K., MINTAS M.: Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties. Eur. J. Med. Chem., 34: 405-413,1999.
  150. PAVELIĆ K.: Molecular Genetics of Malignant Insulinomas. In: Diseases of Pancreas, Biliary Tract and Duodenum. Day of Dialogue in Diagnostic Dilemmas (edited by. Ferlan-Marolt V., Luzar B., Pavelić K., Vucelić B.) Institute of Pathology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia,1999.
  151. PAVELIĆ, K., KAPITANOVIĆ, S., BURA, M., SEIWERTH, S., PAVELIĆ, LJ., SPAVENTI, R.: Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. J.Mol. Med., 78:111-118,2000.
  152. KAPITANOVIĆ S., RADOŠEVIĆ S., SLADE N., KAPITANOVIĆ M., ANĐELINOVIĆ Š., FERENČIĆ Ž., TAVASSOLI M., SPAVENTI Š., PAVELIĆ K., SPAVENTI R.: Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival. J. Cancer Res. Clin. Oncol., 126:205-211, 2000.
  153. GROET J., IVES J.H., JONES T.A., DANTON M., FLOMEN R.H., SHEER D., HRAŠĆAN R., PAVELIĆ K., NIŽETIĆ D.: Narroving of the region of allelic loss in 21q11-21 in squamous non-small cell lung carcinoma and cloning of a novel ubiquitin-specific protease gene from the deleted segment. Genes, Chromosomes & Cancer, 27:153-161,2000.
  154. PAVELIĆ J., LAMOVEC J., NOVAK J., GALL-TROŠELJ K., KAPITANOVIĆ S., PAVELIĆ K.: Collision tumour in the pelvic cavity: rectal leiomyosarcoma and prostate adenocarcinoma. JCancerRes. Clin. Oncol, 126:95-100, 2000.
  155. ROKNIĆ S., GLAVAŠ-OBROVAC LJ., KARNER I., PIANTANIDA I., ŽINIĆ M., PAVELIĆ K.: In vitro cytotoxicity of three 4,9-diazapyrenium hydrogensulfate derivatives on different human tumor cell lines. Chemotherapy, 46:143-149, 2000.
  156. GRCE M., HUSNJAK K., SKERLEV M., LIPOZENČIĆ J., PAVELIĆ K.: Detection and typing of human papillomaviruses bz means of polymerase chain reaction and fragment lentgh polymorphism in male genital lesions. Anticancer Res. 20:2097-2102, 2000.
  157. COLIC M., PAVELIC, K.: Molecular mechanisms of anticancer activity of natural dietetic products. J. Mol. Med., 78:333-336, 2000.
  158. HUSNJAK K., GRCE M., MAGDIĆ L., PAVELIĆ K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J. Virol. Methods, 88:125-134, 2000.
  159. RAVLIĆ-GULAN J., RADOŠEVIĆ-STAŠIĆ B., GULAN G., ŠTIMAC D., PAVELIĆ K., RUKAVINA D.: Immunoprotective properties of peptidoglycan monomer linked with zinc in cholestatic jaundice. Int. Arch. Allergy Immunol. 123:354-364, 2000.
  160. PAVELIĆ K., HADŽIJA M., BEDRICA LJ., PAVELIĆ J., ĐIKIĆ I., KATIĆ M., KRALJ  M., HERAK BOSNAR M., KAPITANOVIĆ S., POLJAK-BLAŽI M., KRIŽANAC Š., STOJKOVIĆ R., JURIN M., SUBOTIĆ B., ČOLIĆ M.: Natural zeolite clinoptilolite: new adjuvant in anticancer therapy. J. Mol. Med. 78:708-720, 2001.
  161. KRALJ M., KAPITANOVIĆ S., KOVAČEVIĆ D., LUKAČ J., SPAVENTI Š., PAVELIĆ K.: Effect of the nonsteroidal anti-inflamatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells. J. Cancer Res. Clin. Oncol., 127:173-179, 2001.
  162. POPOVIĆ HADŽIJA M., KAPITANOVIĆ S., RADOŠEVIĆ S., ČAČEV T., MIRT M., KOVAČEVIĆ D., LUKAČ J., HADŽIJA M., SPAVENTI R., PAVELIĆ K.: Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer. J. Mol. Med. 79:128-132, 2001.
  163. GRCE M., HUSNJAK K., BOŽIKOV J., MAGDIĆ L., ZLAČKI M., LUKAČ J., FISTONIĆ I., ŠIKANIĆ-DUGIĆ N., PAVELIĆ K.:Evaluation of genital human papillomavirus infections by polymerase chain reaction among Croatian  women. Anticancer Res., 21:579-584, 2001.
  164. POLJAK-BLAŽI M., KATIĆ M., KRALJ M., ŽARKOVIĆ N., MAROTTI T., BOŠNJAK B., ŠVERKO V.,  BALOG T., PAVELIĆ K:  In vitro and in vivo effect of natural clinoptilolite on malignant tumors. Stud. Surf. Sci. Catal. 135:5309-5316, 2001.
  165. K. PAVELIĆ K., SUBOTIĆ B., ČOLIĆ M.: Biomedical applications of zeolites. Stud. Surf. Sci. Catal. 135:5309-5316, 2001.
  166. KAPITANOVIĆ S., ČAČEV T., SPAVENTI R., PAVELIĆ K.. Submerged gel electrophoresis on sephadex gels- a new method for APC gene mutation detection.  J. Mol. Med., 79:333-337, 2001.
  167. PAVELIĆ K., KRIŽANAC Š., ČAČEV T., POPOVIĆ HADŽIJA M., RADOŠEVIĆ S., CRNIĆ I., LEVANAT S., KAPITANOVIĆ S.: Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis – clinical evidence in lung and head and neck carcinomas. Molecular  Medicine, 7: 442-453, 2001.
  168. GLAVAS-OBROVAC LJ., KARNER I., ZINIC B., PAVELIC K.: Antineoplastic activity of novel N-1-sulfonypyrimidine derivatives. Anticancer Res., 21:1979-1986, 2001.
  169. PAVELIĆ K., GALL-TROŠELJ K.: Recent advances in molecular genetics of breast cancer. J. Mol. Med., 79:566-573, 2001.
  170. HEĆIMOVIĆ S., VLAŠIĆ J., BARIŠIĆ I., MARKOVIĆ D., ČULIĆ V., PAVELIĆ K.: A simple and rapid analysis of triplet repeat diseases by expand long PCR. Clin. Chem. Lab. Med. 39: 1259-1262, 2001.
  171. PAVELIĆ K., KATIĆ M., ŠVERKO V., MAROTTI T., BOŠNJAK B., BALOG T., STOJKOVIĆ R., RADAČIĆ M., ČOLIĆ M., POLJAK-BLAŽI M.. Immunostimulatory effect of natural clinoptilolite as a possible mechanism of its antimetastatic ability. J. Canc. Res. Clin. Oncol., 128:37-44,  2002.
  172. HEĆIMOVIĆ S., BAGO R., MUŽINIĆ D., BEGOVIĆ D., PAVELIĆ K.: The first case of the FRAXE form of inherited mental retardation in Croatia. Eur. J. Pediatr. 161:112-113 , 2002.
  173. HEĆIMOVIĆ S., PETEK TARNIK I., BARIĆ I., ČAKARUN Ž., PAVELIĆ K.: Screening for fragile X syndrome: results from a school for mentally retarded children. Acta Paediatr. 91:535-539, 2002.
  174. HEĆIMOVIĆ S., KLEPAC N., VLAŠIĆ J., VOJTA A., JANKO D., ŠKARPA-PRPIĆ I., CANKI-KLAIN N., MARKOVIĆ D., BOŽIKOV J., RELJA M., PAVELIĆ K.: Genetic background of Huntington disease in Croatis: Molecular analysis of CAG, CCG, and d2642 (E2642del) polymorphysms. Human Mutation #526  2002.
  175. PAVELIĆ J., PAVELIĆ LJ., KARADŽA J., KRIŽANAC Š., UNEŠIĆ J., SPAVENTI Š., PAVELIĆ K.: Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma. Molecular Medicine 8:149-157, 2002.
  176. PEĆINA-ŠLAUS N., GALL-TROŠELJ K., KAPITANOVIĆ S., PAVELIĆ J., PAVELIĆ K.: Novel alleles of the D16S752 polymorphic genetic marker linked to E-Cadherin Gene – A potential population marker. Coll. Antropol. 26:85-88, 2002.
  177. PAVELIĆ K., BUKOVIĆ D., PAVELIĆ J.: The role of insulin-like growth factor 2 and its receptors in human tumors. Review. Molecular Medicine,  8:771-780, 2002.
  178. DOGAN-KORUŽNJAK J., SLADE N., ZAMOLA B., PAVELIĆ K., KARMINSKI-ZAMOLA G.: Synthesis, photochemical synthesis and antitumor evaluation of novel derivatives of thieno(3‘,2‘:4,5)thieno(2,3-c)quinolones. Chem. Pharm. Bull., 50:656-660, 2002.
  179. COLIC M., PAVELIC K.: Molecular, cellular and medical aspects of the action of nutraceuticals and small molecules therapeutics: from chemoprevention to new drug development. Drugs Exptl. Clin. Res. 26:169-175, 2002.
  180. COLIC M., PAVELIC K.: Cellular mechanisms of immunomodulatory activities of silicate materials. J. Tumour Marker Oncol., 18:63-68, 2002.
  181. DZOLIC Z., KRISTOFOR V., CETINA M., NAGL A., HERGOLD-BRUNDIC D., MRVOS-SERMEK T., BURGEMEISTER M., GRDISA N., SLADE K., PAVELIC K., BALZARINI J., DECLERCQ E., MINTAS M.: Synthesis, structural studies and biological evaluation of some purine substituted 1.aminocyclopropane-1-carboxylic acids and   1-amino-1-hydroxymethylcyclopropanes. Nucleosides Nucleotide & Nucleic Acid 22:373-389, 2003.
  182. ZARKOVIC N., ZARKOVIC  K., KRALJ  M., BOROVIC S., SABOLOVIC S., POLJAK BLAZI M., CIPAK A., PAVELIC K.: Anticancer and antioxidative effects of micronized zeolite clinoptilolite. Anticancer Res. 23:1589-1596, 2003.
  183. DZOLIC Z., CETINA M., KOVACEK D., HERGOLD-BRUNDIC A., MRVOS-SERMEK D., NAGL A., SLADE N., PAVELIC K., BALZARINI J., DE CLERCQ E., ZERBE O., FOLKERS G., SCAPOZZA L., MINTAS M.: Molecular structures and ab initio molecular orbital calculations of the optically active derivatives of 1-aminocyclopropane-1-carboxylic acid. J. Mol. Struct. 655:229-241, 2003.
  184. SARIC T., MULLER D., SEITZ H.J., PAVELIC K.: Non-covalent interaction of ubiquitin with insulin-degrading enzyme. Mol. Cell. Endocrinol. 204:11-20, 2003.
  185. DOGAN  KORUZNJAK J., GRDISA M., SLADE N., ZAMOLA B., PAVELIC K., KARMINSKI-ZAMOLA G.: Novel derivatives of benzo(b)thienol(2,3-c)quinolones: synthesis, photochemical synthesis and antitumor evaluation. J. Med. Chem. 46:4516-4524, 2003.
  186. KRALJ M., PAVELIĆ K.: Medicine on a small scale.  How molecular medicine can benefit from self-assembled and nanostructured materials? EMBO Rep. 4: 1008-1012, 2003.
  187. HRANJEC M., GRDIŠA M., PAVELIĆ K., BOYKIN D.W., KARMINSKI-ZAMOLA G.: Synthesis and antitumor evaluation of some new substituted amidino-benzimidazolyl-furyl-phenyl-acrylates and naphthol/2,1,-b/furan-carboxylates. Il Farmaco 58:1319-1324, 2003.
  188. PAVELIC K., KOLAK T., KAPITANOVIC S., RADOSEVIC S., SPAVENTI S., KRUSLIN B., PAVELIC J.: Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R). J. Pathol. 201:430-438, 2003.
  189. PREKUPEC S.,SVEDRUŽIĆ D., GAZIVODA T., MRVOŠ-SERMEK D, NAGL A., GRDIŠA M., PAVELIĆ K., BALZARINI J., DECLERCQ E.,  FOLKERS G., SCAPOZZA L., MINTAS M., RAIĆ-MALIĆ S.: Synthesis and biological evaluation of iodinated and fluorinated 9-(2-hydroxypropyl) and 9-(2-hydroxyethoxy)methyl purine nucleoside analogues. J. Med. Chem., 46:5763-5772, 2003.
  190. PAVELIĆ K., HADŽIJA M.: Medical application of zeolites. In: Handbook of Zeolite Science and Technology. (edited by  Auerbach S.M., Carrado K.A., Dutta P.K.) Marcel Dekker, New York,  1141-1172, 2003.
  191. GRCE M., HUSNJAK K:, MATOVINA M., MILUTIN N., MAGDIĆ L., HUSNJAK K., PAVELIC, K.: Human papillomavirus, cytomegalovirus, and adeno-associated virus infections in pregnant and nonpregnant women with cervical intraepithelial neoplasia. J. Clin. Microbiol. 42: 1341-1344, 2004.
  192. POPOVIĆ-HADŽIJA M., RADOŠEVIĆ S., KOVAČEVIĆ D., LUKAČ J., HADŽIJA M., SPAVENTI R., PAVELIĆ K., KAPITANOVIĆ S.: Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Mutation Res. 548:61-73, 2004.
  193. RAIC-MALIC.S.,  TOMASKOVIC L.,  MRVOS-SERMEK D., PRUGOVECKI B., CETINA M., GRDISA M., PAVELIC K., MANNSCHRECK A., BALZARINI J., DE CLERCQ E., MINTAS M.: Spirobipyridopyrans, spirobinaphtopyrans, indolinospiropyridopyrans, indolinospironaphthopyrans and indoliunospironaphtho-1,4,-oxazines: synthesis, study of X-ray crystal structure,  antitumoral and antiviral evaluation. Bioorganic Medicinal Chemistry 12: 1037-1045, 2004.
  194. KOWANETZ K., HUSNJAK K., HOLLER D., KOWANETZ M., SOUBEZRAN P., HIRSCH D., SCHMIDT M.H.H., PAVELIC K., DE CAMILLI P., RANDAZZO P.A., DIKIC I.: CIN85 associates with multiple effectors controlling intracellular trafficking of EGF receptors. Mol. Biol. Cell.,  15: 3155-3166, 2004.
  195. ĆALETA I., GRDIŠA M., MRVOŠ-SERMEK D., CETINA M., TRALIĆ-KULENOVIĆ V., PAVELIĆ K., KARMINSKI-ZAMOLA G.: Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles. Il Farmaco. 59:297-305, 2004.
  196. PEĆINA-ŠLAUS N., GALL-TROŠELJ K., ŠLAUS M., RADIĆ K., NIKUŠEVA-MARTIĆ T., PAVELIĆ K.: Genetic changes of the E-cadherin and APC tumor tuppressor genes in clear cell renal cell carcinoma. Pathology 36: 1-7, 2004.
  197. KRALJEVIC S., STAMBROOK P.J., PAVELIC K.: Accelerating drug discovery. EMBO Rep. 5:  837-842, 2004.
  198. BATINAC S., MRVOŠ SERMEK D., CETINA M., PAVELIĆ K., MINTAS M., RAIĆ-MALIĆ S.: Sinthesis of the novel bicyclic oxepinopyrimidine and fluorinated pyrrolidinopyrimidines. Heterocycles, 63:2523-2536, 2004.
  199. KAPITANOVIĆ S., ČAČEV T., RADOŠEVIĆ S., SPAVENTI Š., SPAVENTI R.,  PAVELIĆ K.,: APC gene loss of heterozygosity, mutations, E1317Q, and I1317K germ-line variants in sporadic colon cancer in Croatia. Exp. Mol. Pathol. 77:193-200, 2004.
  200. POPOVIĆ-HADŽIJA M., HRAŠČAN R., HERAK-BOSNAR M., ZELJKO Ž., HADŽIJA M., ČADEŽ J., PAVELIĆ K., KAPITANOVIĆ S.: Alterations of the DPC4 tumor-suppressor gene in renal cell carcinoma. Urolog. Res. 32:229-235, 2004.
  201. KAPITANOVIĆ S., ČAČEV T., BERKOVIĆ M., POPOVIĆ-HADŽIJA M., RADOŠEVIĆ S., SEIWERTH S., SPAVENTI Š., PAVELIĆ K., SPAVENTI R.: nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J. Clin. Pathol.  57: 1312-1318, 2004.
  202. JARAK I., KRALJ M., ŠUMAN L., PAVLOVIĆ G., DOGAN J., PAVELIĆ K., KARMINSKI-ZAMOLA G.: 2-carboxanilides and benzo(b) thieno(2, 3-c)quinolones: synthesis, photochemical synthesis, crystal structure determination and antitumor evaluation.  Part 2.  J. Med. Chem. 48:2346-2360, 2005.
  203. PREKUPEC S., KALOKIRA B., GRDIŠA M., PAVELIĆ K.,  DECLERCQ E., MINTAS M., RAIĆ-MALIĆ S. Synthesis and comparative cytostatic activity of the new N-7 acyclic purine nucleoside analogues with natural N-9 regioisomers. Heterocycles 65:787-797, 2005.
  204. OPAČIĆ N., BARBARIĆ M., ZORC B., CETINA M., NAGL A., FRKOVIĆ D., KRALJ M., PAVELIĆ K., BALZARINI J., ANDREI G.,  SNOECK R., DE CLERCQ E., RAIĆ-MALIĆ S., MINTAS M.: The novel L- and D-amino acid derivatives of hydroxyurea and hydantoins: synthesis, X-ray crystal struczure study, cytostatic and antiviral evaluations. J. Med. Chem., 48: 475-482, 2005.
  205. PAVELIĆ J., KRIŽANAC Š., KAPITANOVIĆ S., PAVELIĆ LJ., SAMARŽIJA M., PAVIČIĆ F., SPAVENTI Š., JAKOPOVIĆ M., HERCEG-IVANOVI Z., PAVELIĆ K.: The consequences of insulin-like growth factors/receptors dysfunction in lung cancer. Am. J. Respir. Cell Mol. Biol., 32: 65-71, 2005.
  206. KRALJ M., KRALJEVIĆ S., SEDIĆ M., KURJAK A., PAVELIĆ K.: Global approach to perinatal medicine: functional genomics and proteomics. J. Perin. Med.,  33 : 5-16, 2005.
  207. GRCE M., PAVELIĆ K.: Antiviral properties of clinoptilolite . Micropor. Mesopor. Mater., 79:165-169, 2005.
  208. GAZIVODA T., PLEVNIK M., PLAVEC J., KRALJEVIĆ S., KRALJ M., PAVELIĆ K., BALZARINI J., DE CLERCQ E., MINTAS M., RAIĆ-MALIĆ S.: The novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis, one- and two-dimensional  1H and 13C NMR study, cytostatic and antiviral evaluation. Biorg. Med. Chem. 13: 131-139, 2005.
  209. BARBARIĆ M., URŠIĆ S., PILEPIĆ V., ZORC B., HERGOLD-BRUNDIĆ A., NAGL A., GRDIŠA M., PAVELIĆ K., SNOECK R., ANDREI G., BALZARINI J., DECLERCQ E.,  MINTAS M.: Synthesis, X-ray cristal structure study, cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids. J. Med Chem., 48:884-887,  2005.
  210. PREKUPEC S., MAKUC D., PLAVEC J.., KRALJEVIĆ S., KRALJ M.., PAVELIĆ K., ANDREI G., SNOECK R., BALZARINI J., DECLERCQ E., RAIĆ-MALIĆ S., MINTAS M..: The novel 5-methyl 6-acyclic chain substituted pyrimidine derivatives: synthesis, 1H and 13C NMR conformational analysis, antiviral and cytostatic evaluation. Antiviral Chemistry. Chemotherapy., 16: 327-338, 2005.
  211. SIROTKOVIĆ-SKERLEV M., KRIŽANAC S., KAPITANOVIĆ S., HUSNJAK K., UNUŠIĆ J., PAVELIĆ K..: Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesion: Coexpression and correlation with clinicopathologic parameters. Exp. Mol. Pathol.  79 : 42-50, 2005.
  212. ČAČEV T., RADOŠEVIĆ S., SPAVENTI R., PAVELIĆ K., KAPITANOVIĆ S.: NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut, 54:1129-1135, 2005.
  213. KRALJEVIĆ S., PAVELIĆ K.: Navigare necessere est. EMBO Rep 6 : 695-700, 2005.
  214. PAVELIĆ K., ETRA A., GALL-TROSELJ K.: Insights from the front lines of nutraceutical research: The Third International Conference on Mechanisms of Action of Nutraceuticals (ICMAN 3). J. Altern. Complem. Med. 11: 735-738, 2005.
  215. MALOJČIĆ G., PIANTANIDA I., MARINIĆ, M., ŽINIĆ M., MARJANOVIĆ M., KRALJ M., PAVELIĆ K., SCHNEIDER-H.-J. : A novel bis-phenanthridine triamine with pH controlled binding to nucleotides and nucleic acid. Org. Biomol. Chem.  3:4373-4381,2005.
  216. SEDIĆ M., KRALJEVIĆ S., PAVELIĆ K.: Cancer research meets functional genomics – what has been accomplished so far?  In: Molecular diagnostic in medicine. (edited by Luzar B., Poljak M., Glavač D., Balažic J.) Faculty of Medicine University of Ljubljana, Ljubljana, Slovenia 99-108, 2005.
  217. KAPITANOVIĆ S., ČAČEV T.,  ANTICA M., KRALJ M., CAVRIĆ G., PAVELIĆ K., SPAVENTI R.: Effect of indometacin on E-cahherin and ?-catenin expression in HT-29 colon cancer cells. Exp. Mol. Path. 80: 91-96, 2006.
  218. ČAČEV T., JOKIĆ M., SPAVENTI R., PAVELIĆ K., KAPITANOVIĆ S.: Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphism. J. Canc. Res. Clin. Oncol. 132: 200-204, 2006
  219. KATIC M., BOŠNJAK B., GALL-TROŠELJ K., DIKIC I., PAVELIC K.: A clinoptilolite effect on cell media and the consequent effects on tumor cells in vitro. Front. Biosci. 11: 1722-1732, 2006.
  220. GAZIVODA T., WITTINE K., LOVRIĆ I., MAKUC D., PLAVEC J., CETINA M., MRVOS-SERMEK D.,  SUMAN L., KRALJ M.,  PAVELIC K., MINTAS M., RAIC-MALIC S.: Synthesis, structural studies, and cytostatic evaluation of 5,6-di-O-modified L-ascorbic acid derivatives. Carbohydrate Res. 341: 433-442, 2006.
  221. JARAK I., KRALJ M., PIANTANIDA I., SUMAN L., ZINIC M., PAVELIC., KARMINSKI-ZAMOLA G.: Novel cyano- and amidino-substituted derivatives of thieno(2,3-b)- and thieno(3,2-b)thiophene-2-carboxanilides and thieno(3’,2’:4,5)thieno- and thieno(2’,3’:4,5)thieno(2,3-c)quinolones: Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation. Bioorgan. Med. Chem. , 14: 2859-2868, 2006.
  222. STARČEVIĆ K., KRALJ M., PIANTANIDA I., ŠUMAN L., PAVELIĆ K., KARMINSKI-ZAMOLA G.: Synthesis, photochemical synthesis, DNA binding and antitumor evaluation of novel cyano-and amidino-substituted derivatives of naphtho-furans, naphtho-thiophenes, thieno-benzofurans, benzo-dithiophenes and their acyclic precursors. Europ. J. Med. Chem., 41: 925-939,  2006
  223. PAVELIĆ K., PRIMORAC D., VUK-PAVLOVIĆ S.: Integrating new countries into the European Research Area. EMBO Rep., 7 : 458-462, 2006.
  224. PAVELIĆ K., DEDIVITIS R.A., KAPITANOVIĆ S., ČAČEV T., GUIRADO C.R., DANIC D., RADOSEVIC S., BRKIC K., PEGAN B., KRIZANAC S., KUSIC Z., SPAVENTI S., BURA M.: Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Mutation Res. 599: 45-57, 2006.
  225. KRALJEVIC S., SEDIC M., SCOTT M., GEHRING P., SCHLAPBACH R., PAVELIC K.: Casting light on molecular events underlying anti-cancer drug treatment: What can be seen from the proteomic point of view? Cancer  Treat. Rev. 32:619-629, 2006.
  226. KOLUNDŽIĆ R., ORLIĆ D., TRKULJA V., PAVELIĆ K., GALL-TROŠELJ K.: Single nucleotide polymorphism in the interleukin-6 gene promoter, tumor necrosis factor-? gene promoter, and transforming growth factor-?1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty:preliminary study. J. Orthop. Sci. 11: 592-600, 2006.
  227. RAJIC Z., ZORC B., RAIC-MALIC S., ESTER K., KRALJ M., PAVELIC K., BALZARINI J., DECLERCQ E., MINTAS M.: Hydantoin  derivatives of L- and D-amino acids: Synthesis and evaluation of their antiviral and antitumoral activity. Molecules 11:837-848, 2006.
  228. GAZIVODA T., RAIĆ-MALIĆ S., MARJANOVIĆ M., KRALJ M., PAVELIĆ K., BALZARINI J., DECLERCQ E.,  MINTAS M.: The novel C-5 aryl, alkenyl substituted uracil derivatives of L-ascorbic acid: Synthesis, cytostatic, and antiviral activity evaluations. Bioorganic Med. Chem., 15:749-758, 2007.
  229. BARBARIĆ M., KRALJ M., MARJANOVIĆ M., HUSNJAK I., PAVELIĆ K., FILIPOVIĆ-GRČIĆ J., ZORC D., ZORC B.: Santhesis and in vitro antitumor effect of  diclofenac and fenoprofen thiolated and nonthiolated polyaspartamide-drug conjugates. Europ. J. Med. Chem  42: 20-29, 2007.
  230. KRIŠTAFOR V, RAIĆ-MALIĆ S, CETINA M, KRALJ M, ŠUMAN L, PAVELIĆ K, BALZARINI J, DECLERCQ E, MINTAS M. Santhesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues. Bioorganic Med. Chem 14: 8126-8138, 2006.
  231. SIROTKOVIĆ-SKERLEV M., CACEV T., KRIZANAC S., KULIĆ A., PAVELIC K., KAPITANOVIC S.: TNF alpha promoter polymorphism analysis in benign and malignant breast lesions. Exp. Mol. Pathol. 83: 54-58 (2007)
  232. STARČEVIĆ K., KRALJ M., ESTER K., SABOL I., GRCE M., PAVELIĆ K., KARMINSKI-ZAMOLA G.: Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles. Bioorganic Med. Chem. 15: 4419-4426, 2007.
  233. PREKUPEC S., MAKUC D., PLAVEC J., ŠUMAN L., KRALJ M., PAVELIĆ K., BALZARINI J., DE CLERCQ E., MINTAS M., RAIĆ-MALIĆ S. Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, 1H and 13C NMR conformational studies, and antiviral and cytostatic evaluation. J. Med. Chem 50: 3037-3045, 2007.
  234. GAZIVODA T., ŠOKČEVIĆ M., KRALJ M., ŠUMAN L., PAVELIĆ K., DECLERCQ E., ANDREI G., SNOECK R., BALZARINI J., MINTAS M., RAIĆ-MALIĆ S.: Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo(2,3-d)pyrimidine 4’,5’-didehydro-L-ascorbic acid derivatives. J. Med. Chem. 50: 4105-4112, 2007.
  235. HRANJEC M., KRALJ M., PIANTANIDA I., SEDIĆ M., ŠUMAN L., PAVELIĆ K., KARMINSKI-ZAMOLA G.: Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazol/1,2-?)quinolines. Synthesis, ohotochemical synthesis, DNA-binding, and antitumor evaluation, Part 3. J. Med. Chem. 50:5696-5711, 2007.
  236. PAVELIC J, RADAKOVIC B, PAVELIC K: Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate in endometrial adenocarcinomas. Gynecol. Oncol. 105:727-735, 2007.
  237. GAZIVODA T., RAIĆ-MALIĆ S., KRIŠTAFOR V., MAKUC D., PLAVEC J., BRATULIĆ S., KRALJEVIĆ PAVELIĆ S., PAVELIĆ K., NAESENS L., ANDREI G., SNOECK R., BALZARINI J., MINTAS M.: Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues. Bioorganic Med. Chem., 16: 5624-5634, 2008.
  238. DŽIMBEG G., ZORC B., KRALJ M., ESTER K., PAVELIĆ K., ANDREI G., SNOECK R., BALZARINI J., DE CLERCQ E., MINTAS M.: The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: Synthesis, cytostatic and antiviral activity evaluations. Europ. J. Med. Chem. 43: 1180-1187, 2008.
  239. MALČIĆ A., JUKIĆ S., NAIĆ I., PAVELIĆ B., KAPITANOVIĆ S., KRUŠLIN B., PAVELIĆ K.: Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst. J. Oral. Pathol. Med. 37: 294-301, 2008.
  240. HRAŠČAN R., PEĆINA-ŠLAUS N., MARTIĆ T.N., ČOLIĆ J.F., GALL-TROŠELJ K., PAVELIĆ K., KARAPANDŽA N.: Analysis of selected genes in neuroendocrine tumors: insulinomas and phaeochromocytomas. J. Neuroendocr., 20: 1-8, 2008.
  241. SEDIC M, POZNIC M, GEHRIG P, SCOTT M, SCHLAPBACH R, HRANJEC M, KARMINSKI-ZAMOLA G, PAVELIC K, KRALJEVIC PAVELIC S: Differential antiproliferative mechanisms of novel derivative of benzimidazol /1,2-?/quinoline in colon cancer cells depending on their p53 status. Mol. Cancer Ther. 7: 2121-2132, 2008.
  242. PERKOVIĆ, I., BUTULA I., ZORC B., HOCK K., KRALJEVIĆ PAVELIĆ S., PAVELIĆ K., DE CLERCQ E., BALZARINI J., MINTAS M. Novel lipophilic hydroxyurea derivatives: synthesis,cytostatic and antiviral activity evaluations. Chem. Biol. Drug. Des. 71: 546-553, 2008.
  243. BOŠNJAK H., PAVELIC K., KRALJEVIC PAVELIC S.: Towards preventive medicine. High-throughput methods from molecular biology are about to change daily clinical practice. EMBO Rep. 9: 1056-1060, 2008.
  244. HRANJEC M, PIANTANIDA I, KRALJ M, ŠUMAN L, PAVELIĆ K, KARMINSKI-ZAMOLA G: Novel amidino-substituted thienyl- and furylvinylbenzimidazole: Derivatives and their photochemical conversion into corresponding diazacyclopenta(c)fluorenes. Synthesis, interactions with DNA and RNA, and antitumor evaluation 4. J. Med. Chem. 51: 4899-4910, 2008. 
  245. KRALJEVIĆ PAVELIĆ S, SEDIĆ M, HOCK K, VUČINIĆ S, JURIŠIĆ D, GEHRING P, SCOTT M, SCHLAPBACH R, ČAČEV T, KAPITANOVIĆ S, PAVELIĆ S: An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren’s disease. J. Pathol. 217: 524-533, 2009.
  246. ESTER K, HRANJEC M, PIANTANIDA I., ĆALETA I, JARAK I, PAVELIĆ K, KRALJ M, KARMINSKI-ZAMOLA G.: Novel derivatives of pyridylbenzol/b/thiophene-2-carboxamides and benzo/b/thienol/2,3-c/napthyridin-2-ones: Minor structural variations provoke major differences of antitumor action mechanisms. J. Med. Chem. 52: 2482-2492, 2009.
  247. ČALETA I, KRALJ M, MARJANOVIĆ M, BERTOŠA B, TOMIĆ S, PAVLOVIĆ G, PAVELIĆ K, KARMINSKI-ZAMOLA G.: Novel cyno- and amidinobenzothiazolo derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure – Activity relationship (QSAR) analysis. J. Med. Chem. 52: 1744-1756, 2009.
  248. RAJIC Z, BUTULA I, ZORC B, KRALJEVIC PAVELIC S, HOCK K,  PAVELIC K., DECLERCQ E, BALZARINI JH, PRZYBOROWSKA M, OSSOWSKI T, MINTAS M: Cytostatic and antiviral activity evaluations of hydroxamic derivatives of some non-steroidal anti-inflammatory drugs. Chem.Biol. Drug. Des. 73: 328-338, 2009.
  249. RADULESCU  RT, POZNIĆ M, PAVELIĆ K. (2009) Complex formation between metabolic enzymes in tumor cells: unfolding the MDR1-IDE paradigm. Mol. Cancer Ther. 8: 3171-3172, 2009.
  250. KRALJEVIĆ PAVELIĆ S, BRATULIĆ S, HOCK K, JURIŠIĆ D, HRANJEC M, KARMINSKI-ZAMOLA G, ŽINIĆ B, BUJAK M, PAVELIĆ K: Screening of potential prodrugs on cells derived from Dupuytren’s disease patients. Biomed. Pharmacother. 63: 577-585, 2009.
  251. SEDIC M, JURISIC D, STANEC Z, HOCK K, PAVELIC K, KRALJEVIC PAVELIC S.: Functional genomics in identification of drug targets in Dupuytren’s contracture. Frontiers Biosci. 15: 57-64, 2010.
  252. RATKAJ I, ŠTAJDUHAR E,VUČINIĆ S, SPAVENTI Š,BOŠNJAK H, PAVELIĆ K, KRALJEVIĆ PAVELIĆ S. Integrated gene networks in breast cancer development. Functional & Integrative Genomics, 15: 57-64, 2010.
  253. BENCI K, WITTINE K, RADAN M, CETINA M, SEDIC M, KRALJEVIC PAVELIC S, PAVELIC K, DE CLERCQ E, MINTAS M: The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4’-benzamido-2’-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations. Bioorganic. Med. Chem. 18: 6349-6257, 2010
  254. KRALJEVIĆ PAVELIĆ S, SEDIĆ M, POZNIĆ M, RAJIĆ Z, ZORC B, PAVELIĆ K, BALZARINI J, MINTAS M. Evaluation of in vitro biological activity of O-alkylated hydroxamic derivatives of some nonsteroidal anti-inflammatory drugs. Anticancer Res. 30: 3987-3994, 2010.
  255. RACANE L, TRALIĆ-KULENOVIĆ V, KRALJEVIĆ PAVELIĆ S, RATKAJ I, PEIXOTO P, NHILI R, DEPAUW S, HILDEBRAND M-P, DAVID-CORDONNIER M-H, PAVELIĆ K, KARMINSKI-ZAMOLA G:  Novel diamidino-substituted derivatives of phenyl-benzothiazolyl- and dibenzothiazolyl  furans and thiophenes: synthesis, antiproliferative and DNA binding poroperties, J. Med. Chem., 53 : 2418-2432., 2010.
  256. KOZARIĆ-KOVAČIĆ, D.; PAVELIĆ, K.; FILIPAC, V.; CINDRIĆ, M.; VUČINIĆ, S.; KRALJEVIĆ PAVELIĆ, S., “Proteomics and Posttraumatic Stress Disorder (PTSD)” // Coping with Posttraumatic Stress Disorder in Returning Troops: Wounds of War II / Wiederhold, Brenda, K ; (ur.). Amsterdam, Berlin, Tokio, Washington D.C. : IOS Press, Str. 57-61, 2010.
  257. SEDIC M, KRALJEVIC PAVELIC S, CINDRIC M, PERONJA M, WISSERS H, , JOSIC D, CUK M, FUMIC K,  BARIC I, PAVELIC K Plasma biomarker identification in S-adenosylhomocysteine hydrolase deficiency. Electrophoresis. 32: 1970-1975, 2011.
  258. KOLUNDŽIC R, TRKULJA V, MIKOLAUCIC M, KOLUNDŽIC M, PAVELIC KRALJEVIC S, PAVELIC K: Association of interleukin-6 and transforming growth factor-?1 gene polymorphisms with developmental hip dysplasia and severe adult hip osteoarthritis: a preliminary study. Cytokines, 54: 125-128, 2011.
  259. KRALJEVIC PAVELIC S, SEDIC M, BOSNJAK H, SPAVENTI S, PAVELIC K: Metastasis: new perspectives on an old problem. Molecular Cancer, 10: 22-36, 2011.
  260. WITTINE K, BENCI K,  KRALJEVIĆ PAVELIĆ S, PAVELIĆ K, BRATULIĆ S, HOCK K, BALZARINI J, MINTAS M. Synthesis, cytostatic and antiviral activity evaluation of the novel acyclic nucleoside analogues containing a sterically constrained (Z)-4-amino-2-butenyl moiety.  Med.  Chem. Res. DOI 10. 1007/s00044-010-9318-1. 2011.
  261. WITTINE K, STIPKOVIĆ BABIĆ M, KOŠUTIĆ M, CETINA M, RIASSEN K, KRALJEVIĆ PAVELIĆ S, TOMLJENOVIĆ PARAVIĆ A, SEDIĆ M, PAVELIĆ K, MINTAS M.: The new 5- or 6-azapyrimidine and cyanuic acid derivatives of L-ascorbic acid bearing the free C-5 hydroxy or C-4 group at the ethylenic spacer: CD-spectral absolute configuration determination and biological activity evaluations. Europ. J. Med. Chem. 46: 2770-2785, 2011.
  262. HRANJEC M,STARČEVIĆ K, PAVELIĆ KRALJEVIĆ S, LUČIN P, PAVELIĆ K, KARMINSKI- ZAMOLA G: Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Shiff bases related to benzimidazoles. Europ. J. Med. Chem. 46:2274-2279, 2011.
  263. BENCI K, SUHINA T, MANDIĆ L, KRALJEVIĆ PAVELIĆ S, TOMLJENOVIC A, PAVELIĆ K, BALZARINI J, WITTINE K, MINTAS M: The novel 1,2,4-triazole and purine acyclic cyclopropane nucleoside analogues: Synthesis, antiviral and cytostatic activity potency evaluations. Antiviral Chem. Chemother. doi: 10.3851/IMP1762,  2011.
  264. HRANJEC M , LUCIC B, RATKAJ I, KRALJEVIĆ PAVELIC S, PIANTANIDA I, PAVELIC  K, KARMINSKI-ZAMOLA G: Novel imidazo[4,5-b]pyridine and triaza-benzo[c]fluorene derivatives: Synthesis, antiproliferative activity and DNA binding studies. Eur. J. Med. Chem. 46 : 2748-2758, 2011.
  265. WITTINE K, STIPKOVIĆ BABIĆ M, MAKUC D, PLAVEC J, KRALJEVIĆ PAVELIĆ S, SEDIĆ M, PAVELIĆ K, LEYSSEN P, NEYTS J, MINTAS M: The Novel 1,2,4-Triazole-3-carboxamide and 4,5-Disubstituted-imidazole Derivatives of L-ascorbic acid: Synthesis, Anti-HCV and Antitumour Activity Evaluations.  Europ. J. Med. Chem. 2012
  266. RACANE L, KRALJEVIĆ PAVELIĆ S, RATKAJ I, STEPANIĆ V, PAVELIĆ K, TRALIĆ-KULENOVIĆ V, KARMINSKI-ZAMOLA G. Synthesis and antiproliferative evaluation of some new amidino-substituted bis-benzothyazolyl-pyridines and pyrazine.  Eur. J. Med. Chem, 55:108-116, 2012.
  267. RATKAJ I, BUJAK M, JURIŠIĆ D, BAUS L, SEDIĆ  M, BENDELJA K,, PAVELIĆ K, KRALJEVIĆ PAVELIĆ S: Microarray analysis of Dupuytren’s disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway. Cell. Physiol. Biochem..30:927-942, 2012.
  268. BENCI K, MANDIĆ L, SUHINA T, SEDIĆ M, KLOBUČAR M, KRALJEVIĆ PAVELIĆ S, PAVELI K, WITTINE K, MINTAS M: Novel Coumarin Derivatives Containing 1,2,4-Triazole, 4,5-Dicyanoimidazole and Purine Moiety: Synthesis and Evaluation of Cytostatic Activity. Molecules, 17:11010-11025, 2012.
  269. MUNJAS JURKIĆ L, KRALJEVIĆ PAVELIĆ S, CEPANEC I, PAVELIĆ K. Zeolites and orthosilicic acid: new perspectives for therapy. Nutrition & Metabolism, 10:2 doi:10.1186/1743-7075-10-2, 2013.
  270. HRANJEC M , SOVIĆ I, RATKAJ I, PAVLOVIĆ G, ILIĆ N, VALJALO L, , PAVELIC  K, KRALJEVIĆ PAVELIC S, KARMINSKI-ZAMOLA G: Antiproliferative potency of novel benzofuran-2-carboxamides on tumor cell lines: cell death mechanisms and determination of crystal structure  Eur. J. Med. Chem. 59:111-119, 2013.
  271. WITTINE K, POLJAK K, KOVAČ M, MAKUC D, PLAVEC J, BALZARINI J, MARTINOVIĆ T, KRALJEVIĆ PAVELIĆ S, PAVELIĆ K, MINTAS M: The novel 84,5-e)(1,3)diazepine-4,8-dione and acyclic carbamoyl imino-ureido derivatives of imidazole: Synthesis, anti-viral and anti-tumor activity evaluations. Molecules 18:13385-13397, 2013.
  272. ŠABAN N, STEPANIĆ V, VUČINIĆ S, HORVATIĆ A, CINDRIĆ M, PERKOVIĆ I, ZORC B, ORŠOLIĆ N, MINTAS M, PAVELIĆ K, KRALJEVIĆ PAVELIĆ C: Antitumor mechanisms of amino acid hydroxyurea derivatives. Int. J. Mol. Sci.  14:23654-23671, 2013.
  273. RACANE  L,  KRALJEVIC PAVELIC S, NHILI R, DEPAUW S, CONSTANT C-P, RATKAJ I, DAVID-CORDONNIER M-H, PAVELIC K, TRALIC-KULENOVIC V, KARMINSKI-ZAMOLA G: New anticancer active and selective phenylene-bisbenzothiazoles: Synthesis, Antiproliferative Evaluation and DNA binding. Eur. J. Med. Chem, 63:882-912013.
  274. ŠTAJDUHAR E, SEDIĆ M, LENIČEK T, RADULOVIĆ P, KERENJI A, KRUŠLIN B, PAVELIĆ K, KRALJEVIĆ PAVELIĆ S: Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer. Tumor Biology  DOI 10.1007/s13277-014-1827-y, 2014.
  275. KAPITANOVIĆ S, ČAČEV T, LONČAR B, CATELA IVKOVIĆ T, KRIŽANAC Š, PAVELIĆ K: Reduced FHI expression is associated with tumor progression in sporadic colon adenocarcinoma. Exp. Mol. Path. 96:92-97, 2014.
     

 

 

 


updated: 04/15/14 ; 01/18/12
edited by: D. Torbica